Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP173399.RAh3DF-L_pv5tb4MQD4pz8yf0d_xyHpFZQxeoFlxt4OPk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP173399.RAh3DF-L_pv5tb4MQD4pz8yf0d_xyHpFZQxeoFlxt4OPk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP173399.RAh3DF-L_pv5tb4MQD4pz8yf0d_xyHpFZQxeoFlxt4OPk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP173399.RAh3DF-L_pv5tb4MQD4pz8yf0d_xyHpFZQxeoFlxt4OPk130_provenance.
- NP173399.RAh3DF-L_pv5tb4MQD4pz8yf0d_xyHpFZQxeoFlxt4OPk130_assertion description "[Po-husk, apart from lowering LDL-C, also reduced TG, TG related to certain gene variants, TC, Apo B-100, oxLDL, insulin-resistance and systolic BP in mild-moderate hypercholesterolaemic individuals. Thus, the target patients to receive Po-husk would be th]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP173399.RAh3DF-L_pv5tb4MQD4pz8yf0d_xyHpFZQxeoFlxt4OPk130_provenance.
- NP173399.RAh3DF-L_pv5tb4MQD4pz8yf0d_xyHpFZQxeoFlxt4OPk130_assertion evidence source_evidence_literature NP173399.RAh3DF-L_pv5tb4MQD4pz8yf0d_xyHpFZQxeoFlxt4OPk130_provenance.
- NP173399.RAh3DF-L_pv5tb4MQD4pz8yf0d_xyHpFZQxeoFlxt4OPk130_assertion SIO_000772 20413122 NP173399.RAh3DF-L_pv5tb4MQD4pz8yf0d_xyHpFZQxeoFlxt4OPk130_provenance.
- NP173399.RAh3DF-L_pv5tb4MQD4pz8yf0d_xyHpFZQxeoFlxt4OPk130_assertion wasDerivedFrom gad-20150221 NP173399.RAh3DF-L_pv5tb4MQD4pz8yf0d_xyHpFZQxeoFlxt4OPk130_provenance.
- NP173399.RAh3DF-L_pv5tb4MQD4pz8yf0d_xyHpFZQxeoFlxt4OPk130_assertion wasGeneratedBy ECO_0000203 NP173399.RAh3DF-L_pv5tb4MQD4pz8yf0d_xyHpFZQxeoFlxt4OPk130_provenance.
- gad-20150221 importedOn "2015-02-21" NP173399.RAh3DF-L_pv5tb4MQD4pz8yf0d_xyHpFZQxeoFlxt4OPk130_provenance.